Its care delivered with depth, integrity, and experience, right here in the heart of Newport Beach
The genetic test reveals predispositions in peptide signaling pathwaysnot pharmacogenetic metabolism of the drugs themselves
Tirzepatide: Dual GLP-1 and GIP Agonist Independent of Weight Loss Tirzepatide, a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonist, has demonstrated efficacy in improving insulin action and reducing hepatic glucagon action in diet-induced obese mice
Lower risk of weight gain Many people experience weight gain when starting insulin treatment
Tirzepatide Weight Loss is an FDA-approved, non-surgical treatment designed to help individuals achieve effective and sustainable weight loss
Int J Eat Disord 57:286293 Cabou C, Burcelin R (2011) GLP-1, the gut-brain, and brain-periphery axes